← Ishga qaytish
Ushbu ish iqtibos qilgan ishlar
206 ta ish
Ish: Advances in monitoring and therapy from minimal residual disease to CAR-T cells in multiple myeloma and precursor disorders
The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy
Shuguang Zhang, Wen‐Ying Chen, Jihong Zhou +5
Sharh maqola20257 iqtibosABIUnlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies
Ding-Ya Sun, Yijie Hu, Xin Li +3
Sharh maqola20247 iqtibosABIIdecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi, Larry D. Anderson, Nina Shah +25
Maqola20215 iqtibosABIMultidrug resistance in cancer: role of ATP–dependent transporters
Michael M. Gottesman, Tito Fojo, Susan E. Bates
Sharh maqola20024 iqtibosABIHarnessing bacteria for tumor therapy: Current advances and challenges
Lina Guo, Jinsong Ding, Wenhu Zhou
Maqola20233 iqtibosABIPrecision sniper for solid tumors: CAR-NK cell therapy
Sisi Li, Jiajie Jing, Yueming Chen +6
Sharh maqola20253 iqtibosABIMulti-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies
Annamaria Salvati, Viola Melone, Alessandro Giordano +12
Sharh maqola20252 iqtibosABIGPRC5D-Targeted CAR T Cells for Myeloma
Sham Mailankody, Sean M. Devlin, Jonathan Landa +35
Maqola20222 iqtibosABIOff-the-Shelf Chimeric Antigen Receptor T Cells
Norihiro Watanabe, Maksim Mamonkin
Sharh maqola20212 iqtibosABIEndowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing
Sumin Jo, Shipra Das, Alan F. Williams +19
Maqola20222 iqtibosABILiquid chromatography–tandem mass spectrometry for clinical diagnostics
Stefani N. Thomas, Deborah French, Paul J. Jannetto +2
Sharh maqola20222 iqtibosABI